Signal active
Organization
Contact Information
Overview
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
About
Biotechnology, Medical, Therapeutics
2007
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Proteostasis Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $10.8B in funding across 60 round(s). With a team of 51-100 employees, Proteostasis Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Proteostasis Therapeutics, raised $45.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
5
0
$179.3M
Details
2
Proteostasis Therapeutics has raised a total of $179.3M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2015 | Early Stage Venture | 37.0M | ||
2008 | Early Stage Venture | 45.0M |
Investors
Proteostasis Therapeutics is funded by 15 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Proteostasis Therapeutics | - | FUNDING ROUND - Proteostasis Therapeutics | 37.0M |
F-Prime Capital | - | FUNDING ROUND - F-Prime Capital | 37.0M |
Proteostasis Therapeutics | - | FUNDING ROUND - Proteostasis Therapeutics | 45.0M |
F-Prime Capital | - | FUNDING ROUND - F-Prime Capital | 45.0M |
Recent Activity
There is no recent news or activity for this profile.